Is this you? Create Your Porfile
Avatar

Mika Sakurai

Memorial Hospital of South Bend

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mika Sakurai is active.

Explore More

Publication

Featured researches published by Mika Sakurai.

Nihon rinsho. Japanese journal of clinical medicine | 2008

Anti-IL-6 Receptor Antibody

Tomoyuki Igawa; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Atsuhiko Maeda

Archive | 2009

Improved antibody molecule

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi

Archive | 2009

Antibody molecules that bind to il-6 receptor

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi

Archive | 2010

Pharmaceutical formulation containing improved antibody molecules

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi; Chifumi Moriyama; Akira Hayasaka

Archive | 2009

IMPROVED ANTIBODY MOLECULE AGAINST IL-6 RECEPTOR

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi

Archive | 2014

Antigen-binding molecule containing modified antibody variable region

Tomoyuki Igawa; Shojiro Kadono; Naoka Hironiwa; Mika Sakurai

Journal of Nuclear Cardiology | 2007

1.47: Changes in myocardial perfusion and function after PCI in patients with chronic total occlusion of a coronary artery disease without prior MI

Yuko Kawai; Youichi Nozaki; Mika Sakurai; Nagara Tamaki

Archive | 2016

Cytotoxic induction therapeutic agent

淳一 根津; Jun-ichi Nezu; 敦 成田; Atsushi Narita; 敬弘 石黒; Takahiro Ishiguro; 実香 櫻井; Mika Sakurai; 宙丈 白岩; Hirotake Shiraiwa; 奈緒香 廣庭; Naoka Hironiwa; 智之 井川; Tomoyuki Igawa; 由美子 川合; Yumiko Kawai

Archive | 2014

Molécule se liant à l'antigène contenant une région variable d'anticorps modifiée

智之 井川; Tomoyuki Igawa; 正次郎 門野; Shojiro Kadono; 奈緒香 廣庭; Naoka Hironiwa; 実香 櫻井; Mika Sakurai

Archive | 2010

Formulation pharmaceutique contenant des molécules d'anticorps améliorées

Tomoyuki Igawa; Shinya Ishii; Atsuhiko Maeda; Mika Sakurai; Tetsuo Kojima; Tatsuhiko Tachibana; Hirotake Shiraiwa; Hiroyuki Tsunoda; Yoshinobu Higuchi; Chifumi Moriyama; Akira Hayasaka

Explore More

Collaboration

Dive into the Mika Sakurai's collaboration.

Top Co-Authors
Avatar

Tomoyuki Igawa

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Hirotake Shiraiwa

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Atsuhiko Maeda

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Hiroyuki Tsunoda

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Tatsuhiko Tachibana

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Tetsuo Kojima

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Shinya Ishii

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Yoshinobu Higuchi

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Nagara Tamaki

Hokkaido University

View shared research outputs
Top Co-Authors
Avatar

Youichi Nozaki

Memorial Hospital of South Bend

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge